The Ob-Gyn Risk Alliance is a medical professional liability insurance program developed exclusively for Obstetricians and Gynecologists. Our mission is to support and partner with Obstetric and Gynecologic providers in their efforts to reduce medical errors and enhance patient safety while controlling liability loss. We do this by offering Ob-Gyn-focused practice improvement tools and medical liability insurance solutions, along with evidence based risk reduction programs and resources.
We strive to be the insurer of choice for Obstetricians and Gynecologists.
In early January of 2016 the FDA reclassified mesh used for transvaginal repair of pelvic organ prolapse (POP) from a class II to a class III medical device. The reclassification means this use of mesh is now in the high-risk category.
In 2011 the FDA identified potential serious complications associated with transvaginal placement of surgical mesh for POP repair. It conducted an analysis of published scientific literature and reviewed several thousand reports of complications related to transvaginal mesh; it also considered and discussed approximately 200 public comments. Due to this reevaluation, the FDA determined that reclassifying mesh used for transvaginal repair of POP was appropriate.
Join over 35,000 doctors and nurses maximizing the power of data through GNOSIS. Now engaging up to 15% of all OB clinicians in the U.S., GNOSIS for Obstetrics is one of the most prolific education and analytics platforms. This comprehensive program, is transforming how clinicians learn and how healthcare facilities use actionable data to improve quality and patient safety in the high-risk areas of obstetrics including: